Sunday, April 26, 2015 Last update: 3:03 AM
FreshNews.com - Covering Large & Obscure Tech Companies Since 1996

Spiracur Announces Renewal Contract With Novation for Advanced, Mechanically-Powered, Disposable Negative Pressure Wound Care Products

Companies mentioned in this article: Spiracur

SUNNYVALE, CA -- (Marketwired) -- 08/07/14 -- Spiracur, the developer of the only mechanically powered advanced wound care solution that delivers the proven efficacy of Negative Pressure Wound Therapy (NPWT), today announced it has been awarded a three-year contract renewal with Novation, LLC, one of the healthcare industry's leading group purchasing organizations. Spiracur will continue to supply the SNaP® Wound Care System, the ciSNaP® Closed Incision System and new dressing kits to Novation members including VHA Inc., UHC and Provista, LLC.

"We are very pleased to continue our successful partnership with Novation," said Chris Fashek, president and chief executive officer for Spiracur. "Spiracur is committed to helping GPOs provide their members with effective solutions to enhance patient care, realize efficiencies and reduce expenses through clinically proven, innovative wound care products that are now reimbursed in the affiliated hospital outpatient wound clinics."

Spiracur is credited with creating a new category of chronic and acute wound management solutions that combine the benefits of advanced wound care with non-powered NPWT. The SNaP® (Smart Negative Pressure®) System provides patients with a sophisticated, non-invasive and disposable NPWT system designed to promote wound healing, which weighs only 2.2 ounces and does not require batteries or electricity. The SNaP System is reimbursed in hospital outpatient wound care clinics and physician offices.

"Our continued partnership with Novation allows Spiracur the opportunity to access an extremely large group of members that make up not-for-profit hospitals, non-acute healthcare organizations and non-profit academic institutions throughout the U.S., to provide their customers with the latest clinical advancements in wound therapy, as well as future advancements for a broader patient population," said Dane Shackleford, vice president, global sales and marketing for Spiracur.

About Novation, Winner of the Ethics Inside® Certification
Founded in 1998, Novation is the leading health care supply chain expertise, analytics and contracting company for the more than 100,000 members and affiliates of VHA Inc. and UHC, two national health care alliances, Children's Hospital Association, an alliance of the nation's leading pediatric facilities, and Provista, LLC. Novation provides alliance members with sourcing services, as well as information and data services. Based in Irving, Texas, Novation develops and manages competitive contracts with more than 800 suppliers. Members of VHA, UHC, Children's Hospital Association and Provista used Novation contracts to purchase approximately $49 billion in 2013. Novation has earned the coveted Ethics Inside Certification from Ethisphere Institute, a leading international think tank dedicated to the research and promotion of best practices in corporate ethics and compliance. Novation was also named on Ethisphere's World's Most Ethical Companies list, and is the only company in the health care industry to earn both distinctions for three consecutive years. To learn more about Novation, please follow @NovationNews.

About Spiracur Inc.
Spiracur Inc., headquartered in Sunnyvale, Calif., is a privately held medical device company focused on the development of innovative wound healing technologies. Spiracur was founded out of the Stanford University Biodesign Innovation Program in 2007. Its first product, the SNaP Wound Care System for the treatment of chronic and acute wounds, is the result of patient and clinician feedback that current negative pressure wound therapies were too cumbersome. The company's ciSNaP® Closed Incision System with proprietary controlled tension relief is designed to improve healing of high-risk surgical incisions. Both devices have received 510(k) clearance from the U.S. Food & Drug Administration (FDA) and have received CE Mark approval. Spiracur's proprietary mechanically powered technology does not require batteries or electricity to operate. For more information, please visit http://spiracur.com.

Spiracur, Spiracur logo, SNaP, Smart Negative Pressure, and ciSNaP are registered trademarks of Spiracur Inc.
Ethics Inside® is a registered trademark of Ethisphere Institute.

Image Available: http://www2.marketwire.com/mw/frame_mw?attachid=2652903


Contact:

Media Contact:
Amy Cook
925.552.7893
Email Contact

Investor Contact:
Steve Van Dick
408.701.5300
Email Contact